PGE2 suppression of innate immunity during mucosal bacterial infection

Frontiers in Cellular and Infection Microbiology

Volumn 4, Issue AUG, 2013, Pages

  Agard, Mallory ^a   Asakrah, Saja ^a   Morici, Lisa A ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteria; Cox; Immunotherapeutic; Infection; Mucosal; Prostaglandin

Indexed keywords

CHEMOKINE RECEPTOR CCR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E2; PROSTAGLANDIN;

BACTERIAL INFECTION; BORDETELLA PERTUSSIS; BURKHOLDERIA CEPACIA; BURKHOLDERIA PSEUDOMALLEI; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ESCHERICHIA COLI; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INTESTINE INFECTION; LUNG INFECTION; MACROPHAGE; MYCOBACTERIUM; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA; SIGNAL TRANSDUCTION; STREPTOCOCCUS; VIBRIO CHOLERAE; BACTERIUM; COX; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; IMMUNOLOGY; IMMUNOTHERAPEUTIC; INFECTION; MUCOSAL; MUCOSAL IMMUNITY;

BACTERIA; COX; IMMUNOTHERAPEUTIC; INFECTION; MUCOSAL; PROSTAGLANDIN;

DINOPROSTONE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL;

EID: 84891554092     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2013.00045     Document Type: Review

References (117)

1. A, S. K., Bansal, K., Holla, S., Verma-Kumar, S., Sharma, P., and Balaji, K. N. (2012). ESAT-6 induced COX-2 expression involves coordinated interplay between PI3K and MAPK signaling. Mol. Immunol. 49, 655-663. doi: 10.1016/j.molimm.2011.11.011
2. Alba-Loureiro, T. C., Martins, E. F., Miyasaka, C. K., Lopes, L. R., Landgraf, R. G., Jancar, S., et al. (2004). Evidence that arachidonic acid derived from neutrophils and prostaglandin E2 are associated with the induction of acute lung inflammation by lipopolysaccharide of Escherichia coli. Inflamm. Res. 53, 658-663. doi: 10.1007/s00011-004-1308-7
3. Aronoff, D. M. (2012). Cyclooxygenase inhibition in sepsis: is there life after death? Mediat. Inflamm. 2012:696897. doi: 10.1155/2012/696897
4. Aronoff, D. M., Bergin, I. L., Lewis, C., Goel, D., O'Brien, E., Peters-Golden, M., et al. (2012). E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae. Prostaglandins Other Lipid Mediat. 98, 23-30. doi: 10.1016/j.prostaglandins.2012.03.002
5. Aronoff, D. M., Canetti, C., and Peters-Golden, M. (2004). Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J. Immunol. 173, 559-565.
6. Aronoff, D. M., Lewis, C., Serezani, C. H., Eaton, K. A., Goel, D., Phipps, J. C., et al. (2009). E-prostanoid 3 receptor deletion improves pulmonary host defense and protects mice from death in severe Streptococcus pneumoniae infection. J. Immunol. 183, 2642-2649. doi: 10.4049/jimmunol.0900129
7. Asakrah, S., Nieves, W., Mahdi, Z., Agard, M., Zea, A. H., Roy, C. J., et al. (2013). Post-exposure therapeutic efficacy of COX-2 inhibition against Burkholderia pseudomallei. PLoS Negl. Trop Dis. 7:e2212. doi: 10.1371/journal.pntd.0002212
8. Ballinger, M. N., Aronoff, D. M., McMillan, T. R., Cooke, K. R., Olkiewicz, K., Toews, G. B., et al. (2006). Critical role of prostaglandin E2 overproduction in impaired pulmonary host response following bone marrow transplantation. J. Immunol. 177, 5499-5508.
9. Bankhurst, A. D. (1982). The modulation of human natural killer cell activity by prostaglandins. J. Clin. Lab. Immunol. 7, 85-91.
10. Bansal, K., Narayana, Y., Patil, S. A., and Balaji, K. N. (2009). M. bovis BCG induced expression of COX-2 involves nitric oxide-dependent and -independent signaling pathways. J. Leukoc. Biol. 85, 804-816. doi: 10.1189/jlb.0908561
11. Berthelot, P., Attree, I., Plésiat, P., Chabert, J., de Bentzmann, S., Pozzetto, B., et al. (2003). Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes. J. Infect. Dis. 188, 512-518. doi: 10.1086/377000
12. Bowman, C. C., and Bost, K. L. (2004). Cyclooxygenase-2-mediated prostaglandin E2 production in mesenteric lymph nodes and in cultured macrophages and dendritic cells after infection with Salmonella. J. Immunol. 172, 2469-2475.
13. Bozyk, P. D., and Moore, B. B. (2011). Prostaglandin E2 and the pathogenesis of pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 45, 445-452. doi: 10.1165/rcmb.2011-0025RT
14. 2 synthesis in a murine macrophage cell line. J. Pharmacol. Exp. Ther. 244, 765-773.
15. 2-induced inhibition of the PLD activation pathway stimulated by fMLP in human neutrophils is mediated by PKA at the PI3-Kgamma level. Biochem. Pharmacol. 74, 730-741. doi: 10.1016/j.bcp.2007.06.013
16. Burelout, C., Thibault, N., Levasseur, S., Simard, S., Naccache, P. H., and Bourgoin, S. G. (2004). Prostaglandin E2 inhibits the phospholipase D pathway stimulated by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Involvement of EP2 receptors and phosphatidylinositol 3-kinase gamma. Mol. Pharmacol. 66, 293-301. doi: 10.1124/mol.66.2.293
17. Chen, M., Divangahi, M., Gan, H., Shin, D. S., Hong, S., Lee, D. M., et al. (2008). Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J. Exp. Med. 205, 2791-2801. doi: 10.1084/jem.20080767
18. Cheng, A. C., and Currie, B. J. (2005). Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18, 383-416. doi: 10.1128/CMR.18.2.383-416.2005
19. Cirillo, D. M., Valdivia, R. H., Monack, D. M., and Falkow, S. (1998). Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol. Microbiol. 30, 175-188. doi: 10.1046/j.1365-2958.1998.01048.x
20. Cockeran, R., Steel, H. C., Mitchell, T. J., Feldman, C., and Anderson, R. (2001). Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils. Infect. Immun. 69, 3494-3496. doi: 10.1128/IAI.69.5.3494-3496.2001
21. Cockeran, R., Theron, A. J., Steel, H. C., Matlola, N. M., Mitchell, T. J., Feldman, C., et al. (2001). Proinflammatory interactions of pneumolysin with human neutrophils. J. Infect. Dis. 183, 604-611. doi: 10.1086/318536
22. Cristina Cerquetti, M., Hovsepian, E., Sarnacki, S. H., and Goren, N. B. (2008). Salmonella enterica serovar Enteritidis dam mutant induces low NOS-2 and COX-2 expression in macrophages via attenuation of MAPK and NF-kappaB pathways. Microbes Infect. 10, 1431-1439. doi: 10.1016/j.micinf.2008.08.008
23. Divangahi, M., Chen, M., Gan, H., Desjardins, D., Hickman, T. T., Lee, D. M., et al. (2009). Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10, 899-906. doi: 10.1038/ni.1758
24. Dupuy, S., Lambert, M., Zucman, D., Choukem, S. P., Tognarelli, S., Pages, C., et al. (2012). Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma. PLoS Pathog. 8:e1002486. doi: 10.1371/journal.ppat.1002486
25. Eckmann, L., Stenson, W. F., Savidge, T. C., Lowe, D. C., Barrett, K. E., Fierer, J., et al. (1997). Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. J. Clin. Invest. 100, 296-309. doi: 10.1172/JCI119535
26. Edwards, C. K., Hedegaard, H. B., Zlotnik, A., Gangadharam, P. R., Johnston, R. B., and Pabst, M. J. (1986). Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma. J. Immunol. 136, 1820-1827.
27. Ejima, K., Layne, M. D., Carvajal, I. M., Kritek, P. A., Baron, R. M., Chen, Y. H., et al. (2003). Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death. FASEB J. 17, 1325-1327. doi: 10.1096/fj.02-1078fje
28. Filion, F., Bouchard, N., Goff, A. K., Lussier, J. G., and Sirois, J. (2001). Molecular cloning and induction of bovine prostaglandin E synthase by gonadotropins in ovarian follicles prior to ovulation in vivo. J. Biol. Chem. 276, 34323-34330. doi: 10.1074/jbc.M103709200
29. Finch, R. (2001). Community-acquired pneumonia: the evolving challenge. Clin. Microbiol. Infect. 7(Suppl. 3), 30-38.
30. Fink, J., Steer, J. H., Joyce, D. A., McWilliam, A. S., and Stewart, G. A. (2003). Pro-inflammatory effects of Burkholderia cepacia on cystic fibrosis respiratory epithelium. FEMS Immunol. Med. Microbiol. 38, 273-282. doi: 10.1016/S0928-8244(03)00169-X
31. Fitzpatrick, F. A., Aguirre, R., Pike, J. E., and Lincoln, F. H. (1980). The stability of 13, 14-dihydro-15 keto-PGE2. Prostaglandins 19, 917-931. doi: 10.1016/0090-6980(80)90126-4
32. Fujino, H., Salvi, S., and Regan, J. W. (2005). Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. Mol. Pharmacol. 68, 251-259.
33. Fujino, H., Xu, W., and Regan, J. W. (2003). Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J. Biol. Chem. 278, 12151-12156. doi: 10.1074/jbc.M212665200
34. García-Del Portillo, F., Pucciarelli, M. G., and Casadesús, J. (1999). DNA adenine methylase mutants of Salmonella typhimurium show defects in protein secretion, cell invasion, and M cell cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 96, 11578-11583. doi: 10.1073/pnas.96.20.11578
35. Glibetic, M., Samlalsingh-Parker, J., Raykova, V., Ofenstein, J., and Aranda, J. V. (2001). Group B Streptococci and inducible nitric oxide synthase: modulation by nuclear factor kappa B and ibuprofen. Semin. Perinatol. 25, 65-69. doi: 10.1053/sper.2001.23181
36. Goldmann, O., Hertzén, E., Hecht, A., Schmidt, H., Lehne, S., Norrby-Teglund, A., et al. (2010). Inducible cyclooxygenase released prostaglandin E2 modulates the severity of infection caused by Streptococcus pyogenes. J. Immunol. 185, 2372-2381. doi: 10.4049/jimmunol.1000838
37. Goto, T., Herberman, R. B., Maluish, A., and Strong, D. M. (1983). Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity. J. Immunol. 130, 1350-1355.
38. Gustafsson, K., Ingelsten, M., Bergqvist, L., Nyström, J., Andersson, B., and Karlsson-Parra, A. (2008). Recruitment and activation of natural killer cells in vitro by a human dendritic cell vaccine. Cancer Res. 68, 5965-5971. doi: 10.1158/0008-5472.CAN-07-6494
39. Ham, E. A., Soderman, D. D., Zanetti, M. E., Dougherty, H. W., McCauley, E., and Kuehl, F. A. (1983). Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. Proc. Natl. Acad. Sci. U.S.A. 80, 4349-4353. doi: 10.1073/pnas.80.14.4349
40. Harris, S. G., Padilla, J., Koumas, L., Ray, D., and Phipps, R. P. (2002). Prostaglandins as modulators of immunity. Trends Immunol. 23, 144-150. doi: 10.1016/S1471-4906(01)02154-8
41. Hata, A. N., and Breyer, R. M. (2004). Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 103, 147-166. doi: 10.1016/j.pharmthera.2004.06.003
42. He, L. K., Liu, L. H., Hahn, E., and Gamelli, R. L. (2001). The expression of cyclooxygenase and the production of prostaglandin E2 in neutrophils after burn injury and infection. J. Burn Care Rehabil. 22, 58-64. doi: 10.1097/00004630-200101000-00012
43. Heithoff, D. M., Enioutina, E. Y., Daynes, R. A., Sinsheimer, R. L., Low, D. A., and Mahan, M. J. (2001). Salmonella DNA adenine methylase mutants confer cross-protective immunity. Infect. Immun. 69, 6725-6730. doi: 10.1128/IAI.69.11.6725-6730.2001
44. Hensel, M., Shea, J. E., Waterman, S. R., Mundy, R., Nikolaus, T., Banks, G., et al. (1998). Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol. Microbiol. 30, 163-174. doi: 10.1046/j.1365-2958.1998.01047.x
45. Hessle, C. C., Andersson, B., and Wold, A. E. (2003). Gram-negative, but not Gram-positive, bacteria elicit strong PGE2 production in human monocytes. Inflammation 27, 329-332. doi: 10.1023/B:IFLA.0000006700.41614.21
46. Honda, A., Sugimoto, Y., Namba, T., Watabe, A., Irie, A., Negishi, M., et al. (1993). Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J. Biol. Chem. 268, 7759-7762.
47. Huang, M., Stolina, M., Sharma, S., Mao, J. T., Zhu, L., Miller, P. W., et al. (1998). Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res. 58, 1208-1216.
48. Hubbard, L. L., Ballinger, M. N., Thomas, P. E., Wilke, C. A., Standiford, T. J., Kobayashi, K. S., et al. (2010). A role for IL-1 receptor-associated kinase-M in prostaglandin E2-induced immunosuppression post-bone marrow transplantation. J. Immunol. 184, 6299-6308. doi: 10.4049/jimmunol.0902828
49. Hurley, B. P., Pirzai, W., Mumy, K. L., Gronert, K., and McCormick, B. A. (2011). Selective eicosanoid-generating capacity of cytoplasmic phospholipase A2 in Pseudomonas aeruginosa-infected epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 300, L286-L294. doi: 10.1152/ajplung.00147.2010
50. Inbar, S., Neeman, E., Avraham, R., Benish, M., Rosenne, E., and Ben-Eliyahu, S. (2011). Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS ONE 6:e19246. doi: 10.1371/journal.pone.0019246
51. Isles, A., Maclusky, I., Corey, M., Gold, R., Prober, C., Fleming, P., et al. (1984). Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104, 206-210. doi: 10.1016/S0022-3476(84)80993-2
52. Jonuleit, H., Kühn, U., Müller, G., Steinbrink, K., Paragnik, L., Schmitt, E., et al. (1997). Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27, 3135-3142. doi: 10.1002/eji.1830271209
53. Joshi, P. C., Zhou, X., Cuchens, M., and Jones, Q. (2001). Prostaglandin E2 suppressed IL-15-mediated human NK cell function through down-regulation of common gamma-chain. J. Immunol. 166, 885-891.
54. Kalinski, P. (2012). Regulation of immune responses by prostaglandin E2. J. Immunol. 188, 21-28. doi: 10.4049/jimmunol.1101029
55. Kaliński, P., Hilkens, C. M., Snijders, A., Snijdewint, F. G., and Kapsenberg, M. L. (1997). IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159, 28-35.
56. Kaliński, P., Schuitemaker, J. H., Hilkens, C. M., and Kapsenberg, M. L. (1998). Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 161, 2804-2809.
57. Kis, B., Snipes, J. A., Gaspar, T., Lenzser, G., Tulbert, C. D., and Busija, D. W. (2006). Cloning of cyclooxygenase-1b (putative COX-3) in mouse. Inflamm. Res. 55, 274-278. doi: 10.1007/s00011-006-0083-z
58. Kunkel, S. L., Spengler, M., May, M. A., Spengler, R., Larrick, J., and Remick, D. (1988). Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263, 5380-5384.
59. Kunkel, S. L., Wiggins, R. C., Chensue, S. W., and Larrick, J. (1986). Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem. Biophys. Res. Commun. 137, 404-410. doi: 10.1016/0006-291X(86)91224-6
60. Kurland, J. I., and Bockman, R. (1978). Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J. Exp. Med. 147, 952-957. doi: 10.1084/jem.147.3.952
61. Lambeau, G., and Lazdunski, M. (1999). Receptors for a growing family of secreted phospholipases A2. Trends Pharmacol. Sci. 20, 162-170. doi: 10.1016/S0165-6147(99)01300-0
62. Liu, L., Ge, D., Ma, L., Mei, J., Liu, S., Zhang, Q., et al. (2012). Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer. J. Thorac. Oncol. 7, 1091-1100. doi: 10.1097/JTO.0b013e3182542752
63. Luft, T., Jefford, M., Luetjens, P., Toy, T., Hochrein, H., Masterman, K. A., et al. (2002). Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 100, 1362-1372. doi: 10.1182/blood-2001-12-0360
64. Mailliard, R. B., Alber, S. M., Shen, H., Watkins, S. C., Kirkwood, J. M., Herberman, R. B., et al. (2005). IL-18-induced CD83+CCR7+ NK helper cells. J. Exp. Med. 202, 941-953. doi: 10.1084/jem.20050128
65. Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., et al. (2007). Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44(Suppl. 2), S27-S72. doi: 10.1086/511159
66. Marotta, P., Sautebin, L., and Di Rosa, M. (1992). Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br. J. Pharmacol. 107, 640-641. doi: 10.1111/j.1476-5381.1992.tb14499.x
67. Muthuswamy, R., Mueller-Berghaus, J., Haberkorn, U., Reinhart, T. A., Schadendorf, D., and Kalinski, P. (2010). PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells. Blood 116, 1454-1459. doi: 10.1182/blood-2009-12-258038
68. Nagamatsu, T., and Schust, D. J. (2010). The immunomodulatory roles of macrophages at the maternal-fetal interface. Reprod. Sci. 17, 209-218. doi: 10.1177/1933719109349962
69. Nakayama, T., Mutsuga, N., Yao, L., and Tosato, G. (2006). Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells. J. Leukoc. Biol. 79, 95-104. doi: 10.1189/jlb.0405226
70. Natarajan, G., Glibetic, M., Raykova, V., Ofenstein, J. P., Thomas, R. L., and Aranda, J. V. (2007). Nitric oxide and prostaglandin response to group B streptococcal infection in the lung. Ann. Clin. Lab. Sci. 37, 170-176.
71. 2 and its mimetic ZK 110.841 are potent inhibitors of receptor-mediated activation of human neutrophils. Eicosanoids 4, 21-28.
72. Nishigaki, N., Negishi, M., and Ichikawa, A. (1996). Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist. Mol. Pharmacol. 50, 1031-1037.
73. Obermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R. P., and Kalinski, P. (2011). Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood 118, 5498-5505. doi: 10.1182/blood-2011-07-365825
74. Ochman, H., Soncini, F. C., Solomon, F., and Groisman, E. A. (1996). Identification of a pathogenicity island required for Salmonella survival in host cells. Proc. Natl. Acad. Sci. U.S.A. 93, 7800-7804. doi: 10.1073/pnas.93.15.7800
75. Park, J. Y., Pillinger, M. H., and Abramson, S. B. (2006). Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin. Immunol. 119, 229-240. doi: 10.1016/j.clim.2006.01.016
76. Peres-Buzalaf, C., de Paula, L., Frantz, F. G., Soares, E. M., Medeiros, A. I., Peters-Golden, M., et al. (2011). Control of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandins. Prostaglandins Leukot. Essent. Fatty Acids 85, 75-81. doi: 10.1016/j.plefa.2011.04.024
77. Peterson, J. W., Lu, Y., Duncan, S., Cantu, J., and Chopra, A. K. (1994). Interactions of intestinal mediators in the mode of action of cholera toxin. J. Med. Microbiol. 41, 3-9. doi: 10.1099/00222615-41-1-3
78. Phipps, R. P., Stein, S. H., and Roper, R. L. (1991). A new view of prostaglandin E regulation of the immune response. Immunol. Today 12, 349-352. doi: 10.1016/0167-5699(91)90064-Z
79. Qadri, F., Raqib, R., Ahmed, F., Rahman, T., Wenneras, C., Das, S. K., et al. (2002). Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139. Clin. Diagn. Lab. Immunol. 9, 221-229. doi: 10.1128/CDLI.9.2.221-229.2002
80. Rangel Moreno, J., Estrada García, I., De La Luz García Hernández, M., Aguilar Leon, D., Marquez, R., and Hernández Pando, R. (2002). The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 106, 257-266. doi: 10.1046/j.1365-2567.2002.01403.x
81. Raqib, R., Mia, S. M., Qadri, F., Alam, T. I., Alam, N. H., Chowdhury, A. K., et al. (2000). Innate immune responses in children and adults with Shigellosis. Infect. Immun. 68, 3620-3629. doi: 10.1128/IAI.68.6.3620-3629.2000
82. Rastogi, N., Bachelet, M., and Carvalho de Sousa, J. P. (1992). Intracellular growth of Mycobacterium avium in human macrophages is linked to the increased synthesis of prostaglandin E2 and inhibition of the phagosome-lysosome fusions. FEMS Microbiol. Immunol. 4, 273-279. doi: 10.1111/j.1574-6968.1992.tb05006.x
83. Raymond, B., Crepin, V. F., Collins, J. W., and Frankel, G. (2011). The WxxxE effector EspT triggers expression of immune mediators in an Erk/JNK and NF-κ B-dependent manner. Cell. Microbiol. 13, 1881-1893. doi: 10.1111/j.1462-5822.2011.01666.x
84. Resta-Lenert, S., and Barrett, K. E. (2002). Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2. Gastroenterology 122, 1070-1087. doi: 10.1053/gast.2002.32372
85. Rieser, C., Böck, G., Klocker, H., Bartsch, G., and Thurnher, M. (1997). Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J. Exp. Med. 186, 1603-1608. doi: 10.1084/jem.186.9.1603
86. Rosenstreich, D. L., Vogel, S. N., Jacques, A. R., Wahl, L. M., and Oppenheim, J. J. (1978). Macrophage sensitivity to endotoxin: genetic control by a single codominant gene. J. Immunol. 121, 1664-1670.
87. Rubins, J. B., Mitchell, T. J., Andrew, P. W., and Niewoehner, D. E. (1994). Pneumolysin activates phospholipase A in pulmonary artery endothelial cells. Infect. Immun. 62, 3829-3836.
88. Sadikot, R. T., Blackwell, T. S., Christman, J. W., and Prince, A. S. (2005). Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 171, 1209-1223. doi: 10.1164/rccm.200408-1044SO
89. Sadikot, R. T., Zeng, H., Azim, A. C., Joo, M., Dey, S. K., Breyer, R. M., et al. (2007). Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX-2. Eur. J. Immunol. 37, 1001-1009. doi: 10.1002/eji.200636636
90. Saliba, A. M., Nascimento, D. O., Silva, M. C., Assis, M. C., Gayer, C. R., Raymond, B., et al. (2005). Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU. Cell. Microbiol. 7, 1811-1822. doi: 10.1111/j.1462-5822.2005.00635.x
91. Sato, H., and Frank, D. W. (2004). ExoU is a potent intracellular phospholipase. Mol. Microbiol. 53, 1279-1290. doi: 10.1111/j.1365-2958.2004.04194.x
92. Sato, H., Frank, D. W., Hillard, C. J., Feix, J. B., Pankhaniya, R. R., Moriyama, K., et al. (2003). The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J. 22, 2959-2969. doi: 10.1093/emboj/cdg290
93. Scandella, E., Men, Y., Gillessen, S., Förster, R., and Groettrup, M. (2002). Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100, 1354-1361. doi: 10.1182/blood-2001-11-0017
94. Schulert, G. S., Feltman, H., Rabin, S. D., Martin, C. G., Battle, S. E., Rello, J., et al. (2003). Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J. Infect. Dis. 188, 1695-1706. doi: 10.1086/379372
95. Schulze-Specking, A., Duyster, J., Gebicke-Haerter, P. J., Wurster, S., and Dieter, P. (1991). Effect of fluoride, pertussis and cholera toxin on the release of arachidonic acid and the formation of prostaglandin E2, D2, superoxide and inositol phosphates in rat liver macrophages. Cell. Signal. 3, 599-606. doi: 10.1016/0898-6568(91)90036-T
96. Serezani, C. H., Chung, J., Ballinger, M. N., Moore, B. B., Aronoff, D. M., and Peters-Golden, M. (2007). Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Am. J. Respir. Cell Mol. Biol. 37, 562-570. doi: 10.1165/rcmb.2007-0153OC
97. Somayaji, S. N., Ritchie, S., Sahraei, M., Marriott, I., and Hudson, M. C. (2008). Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts. Infect. Immun. 76, 5120-5126. doi: 10.1128/IAI.00228-08
98. Speelman, P., Rabbani, G. H., Bukhave, K., and Rask-Madsen, J. (1985). Increased jejunal prostaglandin E2 concentrations in patients with acute cholera. Gut 26, 188-193. doi: 10.1136/gut.26.2.188
99. Stables, M. J., Newson, J., Ayoub, S. S., Brown, J., Hyams, C. J., and Gilroy, D. W. (2010). Priming innate immune responses to infection by cyclooxygenase inhibition kills antibiotic-susceptible and -resistant bacteria. Blood 116, 2950-2959. doi: 10.1182/blood-2010-05-284844
100. Stefanelli, P., Teloni, R., Carannante, A., Mariotti, S., Nisini, R., and Gagliardi, M. C. (2012). Neisseria gonorrhoeae triggers the PGE2/IL-23 pathway and promotes IL-17 production by human memory T cells. Prostaglandins Other Lipid Mediat. 99, 24-29. doi: 10.1016/j.prostaglandins.2012.04.002
101. Stolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B., Luo, J., et al. (2000). Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J. Immunol. 164, 361-370.
102. Strassmann, G., Patil-Koota, V., Finkelman, F., Fong, M., and Kambayashi, T. (1994). Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180, 2365-2370. doi: 10.1084/jem.180.6.2365
103. Sugimoto, Y., Namba, T., Honda, A., Hayashi, Y., Negishi, M., Ichikawa, A., et al. (1992). Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J. Biol. Chem. 267, 6463-6466.
104. Szymanski, K. V., Toennies, M., Becher, A., Fatykhova, D., N'Guessan, P. D., Gutbier, B., et al. (2012). Streptococcus pneumoniae induced regulation of cyclooxygenase-2 in human lung tissue. Eur. Respir. J. 40, 1458-1467. doi: 10.1183/09031936.00186911
105. Tai, H. H., Ensor, C. M., Tong, M., Zhou, H., and Yan, F. (2002). Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid Mediat. 68-69, 483-493. doi: 10.1016/S0090-6980(02)00050-3
106. Takenawa, T., Ishitoya, J., and Nagai, Y. (1986). Inhibitory effect of prostaglandin E2, forskolin, and dibutyryl cAMP on arachidonic acid release and inositol phospholipid metabolism in guinea pig neutrophils. J. Biol. Chem. 261, 1092-1098.
107. Takeuchi, K., Kato, S., and Amagase, K. (2010). Prostaglandin EP receptors involved in modulating gastrointestinal mucosal integrity. J. Pharmacol. Sci. 114, 248-261. doi: 10.1254/jphs.10R06CR
108. Talpain, E., Armstrong, R. A., Coleman, R. A., and Vardey, C. J. (1995). Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils. Br. J. Pharmacol. 114, 1459-1465. doi: 10.1111/j.1476-5381.1995.tb13370.x
109. Torrado, E., Robinson, R. T., and Cooper, A. M. (2011). Cellular response to mycobacteria: balancing protection and pathology.Trends Immunol. 32, 66-72. doi: 10.1016/j.it.2010.12.001
110. Uchiya, K., Barbieri, M. A., Funato, K., Shah, A. H., Stahl, P. D., and Groisman, E. A. (1999). A Salmonella virulence protein that inhibits cellular trafficking. EMBO J. 18, 3924-3933. doi: 10.1093/emboj/18.14.3924
111. Uchiya, K., and Nikai, T. (2004). Salmonella enterica serovar Typhimurium infection induces cyclooxygenase 2 expression in macrophages: involvement of Salmonella pathogenicity island 2. Infect. Immun. 72, 6860-6869. doi: 10.1128/IAI.72.12.6860-6869.2004
112. Walker, W., and Rotondo, D. (2004). Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis. Immunology 111, 298-305. doi: 10.1111/j.1365-2567.2004.01810.x
113. Wheeldon, A., and Vardey, C. J. (1993). Characterization of the inhibitory prostanoid receptors on human neutrophils. Br. J. Pharmacol. 108, 1051-1054. doi: 10.1111/j.1476-5381.1993.tb13504.x
114. Wise, H. (1996). The inhibitory effect of prostaglandin E2 on rat neutrophil aggregation. J. Leukoc. Biol. 60, 480-486.
115. Wise, H., and Jones, R. L. (1994). Characterization of prostanoid receptors on rat neutrophils. Br. J. Pharmacol. 113, 581-587. doi: 10.1111/j.1476-5381.1994.tb17029.x
116. Yu, Y., and Chadee, K. (1998). Prostaglandin E2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism. J. Immunol. 161, 3746-3752.
117. Zaslona, Z., Serezani, C. H., Okunishi, K., Aronoff, D. M., and Peters-Golden, M. (2012). Prostaglandin E2 restrains macrophage maturation via E prostanoid receptor 2/protein kinase A signaling. Blood 119, 2358-2367. doi: 10.1182/blood-2011-08-374207